Arrhythmias & electrophysiology

Time course of recurrent arrhythmias in clinical trials of catheter ablation for paroxysmal atrial fibrillation: A pooled analysis

Heart RhythmPublished systematic review of randomized clinical trials

Authors' conclusion

The timing of arrhythmia recurrence after paroxysmal AF catheter ablation is nonuniform, with the relative yield of active monitoring decreasing as time increases from the index intervention. Shortening the postblanking period follow-up may allow for a less expensive clinical trial and enable earlier knowledge translation, without substantially compromising detection of recurrent arrhythmia.

Study context

Population
Patients undergoing catheter ablation for paroxysmal atrial fibrillation (AF) in randomized clinical trials
Participants
10,246 patients42 trials
Outcome
Pooled arrhythmia-free survival after index ablation (inclusive of a 3-month blanking period)
Follow-up
4, 6, 9 and 12 months
Methodological detailspooled analysis, inverse Kaplan-Meier reconstruction of time-to-event distribution
  • Pooled analysis
  • Inverse Kaplan-Meier reconstruction of time-to-event distribution

Pooled result

As reported in the abstract

4 months

90.4%

95% CI 89.8–90.9

6 months

83.4%

95% CI 82.7–84.1

9 months

77.2%

95% CI 76.4–78.0

12 months

72.8%

95% CI 71.9–73.7

Further pooled results

Share of total recurrences occurring by postablation month · months 4, 6 and 9

By month 4
35.9% (CI, 34.9-36.8)
By month 6
61.5% (CI, 59.9-63.0)
By month 9
85.2% (CI, 83.1-87.4)
  • Timing of recurrences front-loaded

Prediction of 12-month arrhythmia-free survival from reported 6-month survival

Absolute mean error
4.2% (standard deviation, 2.8%)

Original publication

Time course of recurrent arrhythmias in clinical trials of catheter ablation for paroxysmal atrial fibrillation: A pooled analysis. Heart Rhythm. Published 6 June 2025. doi:10.1016/j.hrthm.2025.05.075

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.